Dr. Saveen Semage re-appointed as CEO of NMRA
The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.

Latest Headlines in Sri Lanka
- Military deserter arrested for sexually assaulting doctor at Anuradhapura Hospital March 12, 2025
- Tuition teacher under investigation for student assault ignores NCPA summons March 12, 2025
- Sri Lanka maintains stance on Adani, open to investment March 12, 2025
- Doctors strike over delay in arrest of sexual assault suspect March 12, 2025
- Sri Lanka to introduce freelancer registration system for banking and financial benefits March 11, 2025